MESOTHELIOMA AND ASBESTOS LAWYERS: LEADERS IN THE NATION
Weitz & Luxenberg Helps Client to $35 Million Mesothelioma Verdict against Crane Co.
A Weitz & Luxenberg client who for eight years worked removing asbestos from New York-area buildings has won $35 million from industrial products manufacturer Crane Co. The Queens man developed mesothelioma after being repeatedly exposed on the job to asbestos, bringing suit against Crane Co. A New York State Supreme Court jury returned the eight-figure verdict in March. Read more here.
Ellen Relkin Appointed Chair of Plaintiffs' Steering Committee in Stryker Rejuvenate & ABG II Litigation
Ellen Relkin, Esq., has been appointed as Chair of the Plaintiffs' Steering Committee of the New Jersey consolidated Multi-County Litigation in the In Re: Stryker Rejuvenate & ABG II Hip Implant Litigation. The appointment was made by the Hon. Brian R. Martinotti of the New Jersey Superior Court. Ms. Relkin was also appointed as Liaison Counsel -- in that capacity she will coordinate with the New Jersey Superior Court and any other courts (federal or state) handling parallel litigations; as well, she will coordinate with both plaintiffs’ and defense counsel. The Stryker Rejuvenate Litigation -- a multidistrict action comprised of lawsuits filed by injured hip-implant patients nationwide -- was granted Multi-County Litigation status in January and assigned to New Jersey Superior Court, Bergen County (one of three New Jersey Multi-County venues). Since Stryker is a New Jersey resident defendant, plaintiffs from around the country are able to pursue claims in that state. Notably, this suit is the only centralized jurisdiction in the country for Stryker Rejuvenate and ABG II cases. More than 50 cases are currently pending before Judge Martinotti in Bergen County and based on representations in court today, several hundred cases are expected to be filed shortly.
Doctors, Accused of Failing to Tell Man He had Colon Cancer, Agree to Settlement
Weitz & Luxenberg's Medical Malpractice unit, headed by Allan Zelikovic, Esq., has secured a settlement in the case of a man who died after his doctors failed to appropriately warm him he was in the early stages of colon cancer. You can read more about the settlement here.
Weitz & Luxenberg Secures Settlement for Woman who Died of Complications Related to Tonsillectomy Procedure
Weitz & Luxenberg, P.C., has helped secure a major settlement in the tragic case of a woman who died in the days following tonsillectomy surgery. You can read about the result here.
Weitz & Luxenberg Wins $22 Million Asbestos Verdict Against Goodyear Tire & Rubber Co. and Goodyear Canada
Goodyear Tire & Rubber Co. along with Goodyear Canada lost their bid to avoid liability in an asbestos cancer case. The courtroom victory secured this past June by Weitz & Luxenberg was a huge win for the victims -- and it demonstrated yet again why so many prospective plaintiffs call the firm for a free consultation as they seek compensation for serious harm suffered. Read more here.
Weitz & Luxenberg Launches Investigation of Recalled Styker Surgical Tools
April 10 2013 - Stryker Orthopaedics, the company responsible for manufacturing thousands of allegedly defective hip implant devices, has recalled a product designed to assist surgeons perform hip replacement surgeries. You can read more about the recalled Stryker ShapeMatch Cutting Guides here. Don't know what products were used to perform your surgery? Contact us now for a free evaluation.
Monumental Settlement Reached in 2010 BP Oil Spill Litigation
Update: Plaintiffs Steering Committee has released new official documents regarding the BP Settlement. Click to read the following: Frequently Asked Questions Regarding Deepwater Horizon Economic and Property Damages Settlement; Frequently Asked Questions Regarding Deepwater Horizon Medical Benefits Settlement
NEW YORK, March 2, 2012 -- Robin Greenwald, Esq., head of Weitz & Luxenberg's Environmental and Toxic Torts department, serves on the Plaintiffs' Steering Committee (PSC) pursuing compensation for victims of the 2010 British Petroleum (BP) oil spill in the Gulf of Mexico. The PSC today issued the following announcement: "A settlement in principle has been reached with BP that will fully compensate hundreds of thousands of victims of the tragedy. The settlement is to be fully funded by BP, with no cap on the amount BP will pay. BP is obligated to fully satisfy all eligible claims under the terms of the Court-supervised settlement, irrespective of the funds previously set aside....The settlement will hold BP fully accountable to individuals and businesses harmed by the spill....There will be no delay in the processing of economic loss claims...Court supervision will ensure independence, fairness, transparency of process, and accountability...." The oil spill deprived thousands of income they would have earned from tourism and fishing, and caused them to suffer property damage and medical injuries. The PSC has been fighting for nearly two years to see that these men and women receive compensation to help them move forward with their lives in the spill's wake. You can read the press release here and visit our Gulf Oil Spill Section for more settlement information as it becomes available.
WEITZ & LUXENBERG LITIGATION NEWS:
NJ Law Journal reports on Weitz & Luxenberg’s application to centralize handling of Stryker defective hip implants cases
Oct. 25, 2012 -- The New Jersey Law Journal is out today with a news brief about Weitz & Luxenberg's efforts to obtain multicounty litigation designation for the more efficient and convenient handling of a rising tide of lawsuits against Stryker Orthopaedics. The publication reported that about a dozen cases already had been filed in Bergen County Superior Court, each alleging harm from either of two Stryker prosthetic hip implant products – Rejuvenate and ABG II. The journal quoted Weitz & Luxenberg’s Ellen Relkin, Esq., as saying she expects the total number of cases against Stryker “will run into the hundreds … if not more." Read the article here (free registration required). The online news site Law360 also reported on the firm's application for multicounty designation. Read the article here (subscription required). Meanwhile, the New Jersey courts have published notice of Weitz & Luxenberg’s application for multicounty litigation designation. According to that document, the court will accept comments or objections until Nov. 30, 2012. Read the notice here, or click here to read Relkin's article, "Hiding Across the Atlantic."
Weitz & Luxenberg identifies dangers with new hip replacement product, ready to help patients harmed by metal debris
(UPDATE: Stryker has issued a voluntary recall of two hip replacement systems. The Stryker recall press release can be read on the FDA's website. You can read the FDA's notice here.) July 9, 2012 - Stryker Orthopaedics has issued a Field Safety Notice concerning hazards that have been identified with the company’s Rejuvenate prosthetic hips. Potential health risks prompted the issuance in Canada of a Medical Device Recall Listing advising that Stryker Orthopedics has updated the instructions for use for the Rejuvenate Modular Hip System due to revisions potentially associated with fretting and/or corrosion at or about the modular neck junction. Read more here.
Weitz & Luxenberg helps Accutane client to $9 Million verdict
July 11, 2012 - Weitz & Luxenberg today announced their client - a 31-year old mother who used Accutane as a teenager and developed ulcerative colitis - was awarded $9 million by a New Jersey jury. Weitz & Luxenberg trial attorney Peter Samberg, Esq., put on evidence for the firm's client, one step an eight-week trial involving dozens of witnesses and hours of testimony by pharmaceutical industry experts and the client herself. The client's case was tried alongside three other Accutane users represented by Seeger Weiss, LLP; Levin, Papantonio, Thomas Mitchell, Rafferty & Proctor P.A.; and Beggs & Lane. Read the full press release here.
Seven-figure settlement reached in appendicitis death case
June 12, 2012 - Weitz & Luxenberg today announced that it negotiated a seven-figure medical-malpractice settlement on behalf of the estate of a 51-year-old New York woman who died in 2005 from a ruptured appendix. Doctors who examined the wife and mother of two in the hours before her death misdiagnosed her as suffering from ovarian cancer, thereby losing the opportunity to administer proper timely treatment. Allan Zelikovic, Esq., the Weitz & Luxenberg attorney in charge of the case, said the impressive settlement amount paid to the woman’s estate demonstrates the importance of injured parties selecting as their legal counsel a law firm with the right blend of size, strength and compassionate caring.
FDA seeks to clarify safe path for patients with metal-on-metal hips
June 27, 2012 - The FDA is in the midst of a hearing where testimony about the health risks of various metal-on-metal prosthetic hips will help the agency determine how to advise patients and physicians. Rendering testimony will be various researchers and regulatory bodies, as well as manufacturers of the devices themselves. You can read more about Weitz & Luxenberg's metal-on-metal hip litigations here and here.
Commercialization of Gynecare TVT Secur and Gynecare Prolift to cease to cease t to
June 5, 2012 - Ethicon, manufacturer of the Gynecare TVT Secur and Gynecare Prolift systems, as well as several other pelvic mesh devices, has notified the FDA that it will cease commercializing those products. The products, designed to help treat women with Pelvic Organ Prolapse, have been associated with a variety of injuries. Click here to read more. If you have been injured by a similar product, please visit our pelvic mesh section.
FDA Orders Bayer to Provide Stronger Warnings of Yaz Blood Clot Dangers
April 11, 2012 – The maker of Yaz and Yasmin birth-control pills has been ordered by the U.S. Food and Drug Administration to provide packaging labels that more clearly warn unsuspecting consumers of the dangers posed by the contraceptives. According to the FDA, the new labels will include a discussion of studies showing that Yas/Yasmin takers face a threefold greater risk of potentially fatal blood-clotting than do users of others types of birth-control pills. Read more here.
WEITZ & LUXENBERG FIRM NEWS:
American Bar Assn. appoints Ellen Relkin as co-chair of important subcomittee
Jan. 14, 2013 -- Ellen Relkin, Esq., of Weitz & Luxenberg PC, has been appointed co-chair of the American Bar Assn.'s Pharmaceutical and Medical Device Subcommittee for the 2013-14 term. The important subcommittee is part of the Mass Torts Committee within the ABA's Section of Litigation. In a letter to Ms. Relkin, the ABA said it was "excited to have such an esteemed member of the bar joining our committee leadership." Founded in 1878 and now with approximately 400,000 members, the Chicago-based ABA is the world’s largest voluntary professional organization and is committed to advancing the rule of law throughout the United States and around the world.
Nine Weitz & Luxenberg attorneys again tapped for magazine’s New York ‘Super Lawyers’ list
Nine extraordinary attorneys with the Manhattan law firm Weitz & Luxenberg, P.C., once again earned the mantle of New York metropolitan-area “Super Lawyers,” according to the organization that assembles the rarified list. Named as 2012 “Super Lawyers” are: Perry Weitz, Esq.; Arthur Luxenberg, Esq.; Robert J. Gordon, Esq.; Jerry Kristal, Esq.; Paul Pennock, Esq.; Ellen Relkin, Esq.; Lawrence Goldhirsch, Esq.; Michael Roberts, Esq,; and Nicholas Wise, Esq. Read the full story here.
Judges shared invaluable insights in response to questions from Weitz & Luxenberg co-founder at Asbestos Litigation Conference in Beverly Hills
Perry Weitz, Esq., was afforded the rare chance to ask a handful of distinguished California, New York and Pennsylvania judges questions about trends in asbestos jurisprudence when he co-moderated a roundtable on the topic at a conference for attorneys, held March 1-2 in Beverly Hills, Calif. Jurists included: Sherry Klein Heitler, New York State Supreme Court; Emilie H. Elias, Los Angeles Superior Court; Teri Jackson, San Francisco Superior Court; Jo-Lynne Q. Lee, Alameda, Calif., Superior Court; and Sandra Mazer Moss, Philadelphia Court of Common Pleas. Produced by Perrin Conferences, , ,,,,,, ,,,,,,,,,“Cutting-Edge Issues in Asbestos Litigation” aimed to educate plaintiffs’ and defense attorneys about mesothelioma lawsuits, asbestosis lung-cancer cases and other proceedings addressing harms arising from exposure to asbestos. In a separate session at the conference, Mr. Weitz shared a platform with Judge Heitler of the New York Supreme Court, two other attorneys, and an insurance claims director to discuss where asbestos litigation is headed next. Read more here.
The Law Firm has 11 Peer Review
|Weitz & Luxenberg is an accredited business with the Better Business Bureau.|
Weitz & Luxenberg: national Best Lawyers ranking five consecutive years (per rankings appearing in New York Magazine). Read More...
Follow us on Twitter: @WeitzLuxenberg
Follow us on Facebook
Prior results do not guarantee a similar outcome.